Commercial detailing techniques used by pharmaceutical representatives to influence prescribing

被引:45
|
作者
Roughead, EE [1 ]
Harvey, KJ
Gilbert, AL
机构
[1] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia
[2] La Trobe Univ, Sch Publ Hlth, Melbourne, Vic, Australia
来源
关键词
influence techniques; pharmaceutical promotion; pharmaceutical representatives; medical practitioners; physicians; prescribing;
D O I
10.1111/j.1445-5994.1998.tb01953.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To determine the use of influence techniques by pharmaceutical representatives in their encounters with medical practitioners. Method: We identified six influence techniques from the marketing literature which are thought to be commonly used by sales people. These have been termed the principles of reciprocity, friendship/liking, commitment/consistency, social validation, authority, and scarcity. We examined the use of these techniques by analysing audio-recordings of pharmaceutical representatives' presentations to medical practitioners. Results: Sixteen recordings, detailing 64 medicines, were obtained from seven medical practitioners. Reciprocation was the most commonly observed method of influence. Samples, gifts, printed material, patient information leaflets or invitations were offered in all encounters. Appeals to authority figures, where promotional claims were supported by reference to professors or specialists, specialist groups and specialist hospitals, were recorded. Social validation acts, where reference was made to the peer group were also common. Commitment acts were observed to occur in two ways; the first was as a direct request to use the product detailed and the second was as a series of questions or statements which gradually moved from pre-agreed areas to solicitation of a commitment to prescribe the drug. Conclusion: influence techniques were found to be commonly used by pharmaceutical representatives when they detailed products to medical practitioners. Medical practitioners may not be aware of the potential effect these techniques can have on their prescribing practices. Knowledge of these techniques must be incorporated into educational programmes designed to provide health professionals with critical appraisal skills.
引用
收藏
页码:306 / 310
页数:5
相关论文
共 50 条
  • [1] PHYSICIANS, PHARMACEUTICAL REPRESENTATIVES, AND THE COST OF PRESCRIBING
    CAUDILL, TS
    RICH, EC
    JOHNSON, MMS
    MCKINNEY, WP
    [J]. CLINICAL RESEARCH, 1993, 41 (02): : A536 - A536
  • [2] PHYSICIANS, PHARMACEUTICAL REPRESENTATIVES, AND THE COST OF PRESCRIBING
    CAUDILL, TS
    RICH, EC
    JOHNSON, MMS
    MCKINNEY, PW
    [J]. CLINICAL RESEARCH, 1992, 40 (04): : A811 - A811
  • [3] CONTENT-ANALYSIS OF DRUG-DETAILING BY PHARMACEUTICAL REPRESENTATIVES
    HEMMINKI, E
    [J]. MEDICAL EDUCATION, 1977, 11 (03) : 210 - 215
  • [4] Physicians, pharmaceutical sales representatives, and the cost of prescribing
    Caudill, TS
    Johnson, MS
    Rich, EC
    McKinney, WP
    [J]. ARCHIVES OF FAMILY MEDICINE, 1996, 5 (04) : 201 - 206
  • [5] Pharmaceutical representatives - Effective if used with caution
    Shaughnessy, AF
    Slawson, DC
    [J]. BRITISH MEDICAL JOURNAL, 1996, 312 (7045): : 1494 - 1494
  • [6] Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing
    Larkin, Ian
    Ang, Desmond
    Steinhart, Jonathan
    Chao, Matthew
    Patterson, Mark
    Sah, Sunita
    Wu, Tina
    Schoenbaum, Michael
    Hutchins, David
    Brennan, Troyen
    Loewenstein, George
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (17): : 1785 - 1795
  • [7] The assessment of pharmaceutical sales representatives by family physiciansudoes it affect the prescribing index?
    Klemenc-Ketis, Zalika
    Kersnik, Janko
    [J]. FAMILY PRACTICE, 2013, 30 (03) : 320 - 324
  • [8] Pharmaceutical representatives do influence physician behaviour
    Harris, Gwyn
    [J]. FAMILY PRACTICE, 2009, 26 (03) : 169 - 170
  • [9] INFLUENCE OF PHARMACEUTICAL SALES REPRESENTATIVES ON THE FORMULARY SYSTEM
    HOPPE, SA
    GORAHARPER, ML
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (14) : 1549 - 1551
  • [10] Restrictions On Pharmaceutical Detailing Reduced Off-Label Prescribing Of Antidepressants And Antipsychotics In Children
    Larkin, Ian
    Ang, Desmond
    Avorn, Jerry
    Kesselheim, Aaron S.
    [J]. HEALTH AFFAIRS, 2014, 33 (06) : 1014 - 1023